Complete Filing Data
MoonLake Immunotherapeutics reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $304.48 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MoonLake Immunotherapeutics did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$227.3M | -$118.9M | -$36.0M | -$50.0M | -$4.5M |
| Other Comprehensive Income Loss Net Of Tax | -$4.5M | $2.6M | $2.0M | $660.6K | |
| Operating Income Loss | -$244.8M | -$143.1M | -$54.1M | -$65.1M | -$4.6M |
| General And Administrative Expense | $42.0M | $30.3M | $22.3M | $23.0M | $4.6M |
| Net Income Loss Attributable To Noncontrolling Interest | -$3.0M | -$2.3M | -$8.1M | -$14.5M | -$4.5M |
| Research And Development Expense | $202.9M | $112.8M | $31.8M | $42.0M | |
| Operating Expenses | $244.8M | $143.1M | $54.1M | $65.1M | |
| Income Tax Expense Benefit | $611.0K | $282.0K | $94.0K | $36.4K | |
| Comprehensive Income Net Of Tax | -$231.7M | -$116.4M | -$34.5M | -$49.4M | |
| Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax | $641.0K | -$87.0K | -$336.0K | $269.9K | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$234.8M | -$118.6M | -$42.1M | -$63.8M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$3.1M | -$2.3M | -$7.6M | -$14.4M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$5.1M | $2.7M | $2.3M | $390.8K | |
| Other Nonoperating Income Expense | $591.7K | ||||
| Other Nonoperating Income | $22.4M | $22.1M | $10.1M | $591.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$69.7M | -$55.2M | -$39.9M | -$35.4M | -$24.3M | -$13.7M | -$9.4M | -$10.1M | -$9.0M | -$10.1M | -$12.1M | -$15.9M | -$6.3M | -$32.7M | -$76.3K | -$5.0K |
| Other Comprehensive Income Loss Net Of Tax | -$247.0K | -$1.9M | -$2.7M | -$441.0K | $576.0K | $263.0K | $3.5M | -$431.6K | -$17.7K | $166.6K | $101.6K | $266.3K | $1.0K | -$1.0K | ||
| Operating Income Loss | -$71.4M | -$60.7M | -$47.5M | -$43.1M | -$30.6M | -$19.8M | -$13.0M | -$13.2M | -$12.9M | -$14.8M | -$17.7M | -$15.9M | -$6.3M | -$32.7M | -$94.1K | -$5.0K |
| General And Administrative Expense | $10.8M | $10.9M | $11.0M | $7.4M | $6.9M | $6.8M | $5.4M | $4.5M | $5.5M | $5.7M | $6.3M | $5.5M | $5.6M | $2.8M | $94.1K | $5.0K |
| Net Income Loss Attributable To Noncontrolling Interest | -$965.0K | -$831.0K | -$615.0K | -$724.0K | -$492.0K | -$302.0K | -$2.2M | -$2.2M | -$3.2M | -$4.6M | -$5.3M | $0.00 | $0.00 | $0.00 | -$76.3K | -$5.0K |
| Research And Development Expense | $60.6M | $49.8M | $36.5M | $35.7M | $23.7M | $13.0M | $7.6M | $8.7M | $7.4M | $9.0M | $11.4M | $10.5M | $669.5K | $29.9M | ||
| Operating Expenses | $71.4M | $60.7M | $47.5M | $43.1M | $30.6M | $19.8M | $13.0M | $13.2M | $12.9M | $14.8M | $17.7M | $15.9M | $6.3M | $32.7M | ||
| Income Tax Expense Benefit | $115.0K | $95.0K | $153.0K | $92.0K | $79.0K | $70.0K | $28.9K | $10.1K | $11.0K | $8.7K | $9.3K | $7.3K | $0.00 | $0.00 | ||
| Comprehensive Income Net Of Tax | -$70.0M | -$57.1M | -$42.6M | -$35.8M | -$23.7M | -$13.4M | -$6.6M | -$10.5M | -$9.0M | -$10.0M | -$12.1M | -$15.6M | -$6.3M | -$32.7M | ||
| Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax | $8.0K | $13.0K | $95.0K | -$116.0K | -$76.0K | $81.0K | $39.2K | -$16.3K | -$42.1K | $89.6K | $101.6K | $266.3K | $1.0K | -$1.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$70.9M | -$57.9M | -$43.2M | -$36.6M | -$24.2M | -$13.7M | -$8.1M | -$12.8M | -$12.2M | -$14.6M | -$17.3M | -$15.6M | -$6.3M | -$32.7M | ||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$969.0K | -$859.0K | -$656.0K | -$733.0K | -$480.0K | -$296.0K | -$1.6M | -$2.3M | -$3.2M | -$4.6M | -$5.3M | $0.00 | $0.00 | $0.00 | ||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$255.0K | -$1.9M | -$2.8M | -$325.0K | $652.0K | $182.0K | $3.4M | -$415.2K | $24.5K | $77.0K | $0.00 | $0.00 | $0.00 | |||
| Other Nonoperating Income Expense | $1.4M | $842.7K | $723.6K | $37.6K | $245.1K | $69.5K | -$20.8K | -$3.8K | $17.8K | |||||||
| Other Nonoperating Income | $4.1M | $6.8M | $7.1M | $7.1M | $5.9M | $5.9M | $1.4M | $842.7K | $723.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $304.5M | $446.8M | $495.7M | $48.9M | -$11.6M | -$2.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $334.5M | $180.4M | $451.2M | $39.5M | $8.0M | |
| Retained Earnings Accumulated Deficit | -$462.9M | -$235.6M | -$116.7M | -$80.7M | -$53.6M | -$2.5M |
| Liabilities Current | $45.5M | $22.5M | $10.0M | $7.7M | $21.1M | $125.2K |
| Assets | $424.4M | $477.9M | $526.5M | $76.8M | $9.7M | $116.6M |
| Liabilities And Stockholders Equity | $424.4M | $477.9M | $526.5M | $76.8M | $9.7M | $116.6M |
| Liabilities | $120.0M | $24.5M | $13.0M | $8.1M | $21.3M | $4.2M |
| Assets Current | $421.7M | $474.3M | $514.2M | $76.5M | $9.6M | $1.6M |
| Cash And Cash Equivalents At Carrying Value | $334.5M | $180.4M | $451.2M | $39.5M | $8.0M | |
| Property Plant And Equipment Net | $577.0K | $722.0K | $320.9K | $49.4K | $45.7K | |
| Other Receivables Net Current | $4.9M | $2.8M | $1.1M | $217.1K | $148.8K | |
| Liabilities Noncurrent | $74.5M | $2.1M | $3.1M | $411.2K | $239.9K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $154.1M | -$270.7M | $411.7M | $31.5M | ||
| Assets Noncurrent | $2.7M | $3.6M | $12.4M | $332.0K | $45.7K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $604.0K | $5.0M | $2.4M | $350.9K | -$168.2K | |
| Trade And Other Payables Current | $29.6M | $9.0M | $1.8M | $255.0K | $1.6M | |
| Minority Interest | $0.00 | $6.6M | $17.8M | $19.9M | $0.00 | |
| Defined Benefit Pension Plan Liabilities Noncurrent | $0.00 | $621.0K | $583.4K | $282.2K | $239.9K | |
| Accrued Liabilities And Other Liabilities | $14.7M | $12.1M | $6.9M | $7.3M | $4.5M | |
| Available For Sale Securities Debt Securities Current | $59.5M | $267.6M | $59.8M | $32.6M | $0.00 | |
| Operating Lease Right Of Use Asset | $1.6M | $2.9M | $3.6M | $282.6K | $0.00 | |
| Operating Lease Liability Noncurrent | $374.0K | $1.5M | $2.5M | $129.0K | $0.00 | |
| Operating Lease Liability Current | $1.2M | $1.4M | $1.2M | $153.6K | $0.00 | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $555.0K | $3.6M | $435.0K | ||
| Repayments Of Short Term Debt | $0.00 | $0.00 | $15.0M | |||
| Common Stock Value | $43.00 | |||||
| Accrued Liabilities Current | $67.1K | |||||
| Deferred Compensation Liability Classified Noncurrent | $4.0M | |||||
| Assets Held In Trust Noncurrent | $115.0M | |||||
| Temporary Equity Carrying Amount Attributable To Parent | $115.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $288.9M | $353.7M | $407.5M | $488.2M | $520.7M | $542.6M | $424.9M | $489.8M | $42.0M | $55.3M | $63.5M | $24.4M | -$4.8M | $5.0M | -$2.6M | -$2.5M | $20.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $350.7M | $306.7M | $271.6M | $375.7M | $342.8M | $458.4M | $318.2M | $501.8M | $50.1M | $41.2M | $92.7M | $8.8M | $507.6K | $2.0M | $0.00 | |||
| Retained Earnings Accumulated Deficit | -$400.5M | -$330.8M | -$275.5M | -$190.0M | -$154.6M | -$130.3M | -$109.2M | -$99.8M | -$89.7M | -$68.8M | -$58.7M | -$9.8M | -$4.8M | -$319.5K | -$167.1K | -$5.0K | ||
| Liabilities Current | $48.4M | $27.4M | $24.0M | $20.1M | $12.3M | $8.9M | $10.3M | $7.1M | $7.3M | $6.0M | $3.9M | $202.8M | $2.1M | $90.0K | $60.0K | $143.5K | ||
| Assets | $414.3M | $460.1M | $511.3M | $518.2M | $544.9M | $564.1M | $500.2M | $506.6M | $66.8M | $88.6M | $98.4M | $231.2M | $116.2M | $116.4M | $116.5M | $163.5K | ||
| Liabilities And Stockholders Equity | $414.3M | $460.1M | $511.3M | $518.2M | $544.9M | $564.1M | $500.2M | $506.6M | $66.8M | $88.6M | $98.4M | $231.2M | $116.2M | $116.4M | $116.5M | $163.5K | ||
| Liabilities | $123.1M | $102.2M | $98.7M | $22.7M | $14.8M | $11.7M | $10.6M | $7.5M | $7.7M | $6.0M | $3.9M | $206.8M | $6.1M | $4.1M | $4.1M | |||
| Assets Current | $411.2M | $455.5M | $506.3M | $512.3M | $536.9M | $553.6M | $500.0M | $506.4M | $66.5M | $88.5M | $98.4M | $116.2M | $1.2M | $1.3M | $1.5M | |||
| Cash And Cash Equivalents At Carrying Value | $350.7M | $306.7M | $271.6M | $375.7M | $342.8M | $458.4M | $318.2M | $501.8M | $50.1M | $41.2M | $23.3K | $1.0M | $1.1M | $1.2M | $1.3M | |||
| Property Plant And Equipment Net | $622.0K | $667.0K | $711.0K | $581.4K | $481.7K | $509.8K | $39.5K | $42.8K | $46.1K | $52.7K | $56.0K | |||||||
| Other Receivables Net Current | $4.0M | $3.4M | $3.0M | $2.4M | $1.7M | $1.5M | $720.8K | $619.8K | $378.4K | $600.5K | $557.0K | |||||||
| Liabilities Noncurrent | $74.8M | $74.8M | $74.7M | $2.6M | $2.6M | $2.8M | $268.5K | $376.6K | $405.3K | $5.0K | $18.6K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $91.1M | $7.3M | $10.6M | $795.3K | -$165.9K | |||||||||||||
| Assets Noncurrent | $3.1M | $4.6M | $5.0M | $5.9M | $8.0M | $10.5M | $208.9K | $254.0K | $292.4K | $52.7K | $56.0K | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $278.0K | $520.0K | $2.4M | $2.8M | $3.3M | $2.7M | $2.9M | $35.1K | $340.1K | $245.3K | $133.7K | |||||||
| Trade And Other Payables Current | $25.3M | $17.1M | $12.0M | $10.7M | $5.1M | $3.5M | $3.4M | $4.4M | $3.8M | $1.1M | $791.1K | |||||||
| Minority Interest | $2.3M | $4.2M | $5.1M | $7.3M | $9.4M | $9.8M | $64.7M | $9.3M | $17.1M | $27.3M | $31.0M | |||||||
| Defined Benefit Pension Plan Liabilities Noncurrent | $549.0K | $574.0K | $536.0K | $695.0K | $541.9K | $462.7K | $255.4K | $323.6K | $314.2K | $5.0K | $18.6K | |||||||
| Accrued Liabilities And Other Liabilities | $21.6M | $8.7M | $10.5M | $7.9M | $5.8M | $4.1M | $6.7M | $2.6M | $3.3M | $5.0M | $3.1M | |||||||
| Available For Sale Securities Debt Securities Current | $29.7M | $118.4M | $208.6M | $118.3M | $177.0M | $88.6M | $177.8M | $0.00 | $12.9M | $42.3M | ||||||||
| Operating Lease Right Of Use Asset | $1.9M | $2.3M | $2.6M | $3.3M | $3.4M | $3.7M | $169.4K | $211.2K | $246.3K | |||||||||
| Operating Lease Liability Noncurrent | $486.0K | $836.0K | $1.1M | $1.9M | $2.0M | $2.4M | $13.1K | $53.0K | $91.1K | |||||||||
| Operating Lease Liability Current | $1.5M | $1.6M | $1.4M | $1.4M | $1.3M | $1.3M | $156.3K | $158.2K | $155.2K | |||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $370.0K | $0.00 | |||||||||||||||
| Repayments Of Short Term Debt | ||||||||||||||||||
| Common Stock Value | $385.00 | $43.00 | $43.00 | $120.00 | ||||||||||||||
| Accrued Liabilities Current | $5.8M | $3.9M | $2.1M | $90.0K | $60.0K | $90.5K | ||||||||||||
| Deferred Compensation Liability Classified Noncurrent | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | |||||||||||||
| Assets Held In Trust Noncurrent | $115.1M | $115.0M | $115.0M | $115.0M | $115.0M | |||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $115.0M | $115.0M | $107.3M | $107.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$196.0M | -$116.6M | -$42.8M | -$55.9M | -$611.1K |
| Net Cash Provided By Used In Financing Activities | $146.0M | $51.3M | $479.7M | $119.7M | -$58.1K |
| Increase Decrease In Prepaid Expense | -$561.0K | $12.9M | $6.3M | $2.7M | -$156.1K |
| Net Cash Provided By Used In Investing Activities | $203.0M | -$205.6M | -$25.2M | -$32.3M | |
| Share Based Compensation | $12.9M | $7.3M | $7.1M | $9.7M | |
| Payments To Acquire Property Plant And Equipment | $35.0K | $520.0K | $284.0K | $16.0K | |
| Increase Decrease In Other Receivables | $2.0M | $1.8M | $840.0K | $68.4K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $2.6M | $5.2M | -$327.0K | $2.7M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.1M | $128.0K | -$76.0K | $8.5K | |
| Increase Decrease In Accounts Payable | $20.6M | $7.2M | $1.6M | -$1.3M | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $468.4M | $145.2M | $150.8M | $9.9M | |
| Payments To Acquire Available For Sale Securities Debt | $265.4M | $350.3M | $175.7M | $42.2M | |
| Payments Of Stamp Duty | $0.00 | $1.5M | $2.8M | $0.00 | |
| Increase Decrease In Operating Lease Right Of Use Asset | $0.00 | $6.0K | $66.0K | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$1.2M | -$1.4M | -$222.0K | -$152.4K | |
| Proceeds From Issuance Of Common Stock | |||||
| Proceeds From Reverse Recapitalization | $0.00 | $0.00 | $134.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$38.1M | -$14.9M | -$9.0M | -$14.2M | -$107.8K |
| Net Cash Provided By Used In Financing Activities | $73.1M | $51.0M | $0.00 | $15.0M | -$58.1K |
| Increase Decrease In Prepaid Expense | -$273.0K | $833.0K | -$1.1M | $848.0K | $6.6K |
| Net Cash Provided By Used In Investing Activities | $56.2M | -$28.8M | $19.6M | -$16.0K | |
| Share Based Compensation | $2.3M | $1.7M | $2.6M | $2.0M | |
| Payments To Acquire Property Plant And Equipment | $35.0K | $212.0K | $0.00 | $16.0K | |
| Increase Decrease In Other Receivables | $146.0K | $439.0K | $161.3K | $432.8K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.6M | -$2.8M | -$3.9M | -$1.3M | -$7.1K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$88.0K | $46.0K | -$535.00 | -$6.5K | |
| Increase Decrease In Accounts Payable | $3.0M | $1.6M | $3.6M | $2.2M | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $144.8M | $59.1M | $19.6M | $0.00 | |
| Payments To Acquire Available For Sale Securities Debt | $88.5M | $87.7M | $0.00 | ||
| Payments Of Stamp Duty | $0.00 | $1.6M | $0.00 | ||
| Increase Decrease In Operating Lease Right Of Use Asset | $0.00 | $5.0K | $0.00 | ||
| Increase Decrease In Operating Lease Liability | -$255.0K | -$406.0K | -$38.8K | ||
| Proceeds From Issuance Of Common Stock | $0.00 | $52.5M | $0.00 | ||
| Proceeds From Reverse Recapitalization |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.53 | -$1.89 | -$0.73 | -$1.70 | -$0.31 | |
| Weighted Average Number Of Shares Outstanding Basic | 64.5M | 62.9M | 49.1M | 29.4M | ||
| Earnings Per Share Basic | $-3.53 | $-1.89 | $-0.73 | $-1.70 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 64.5M | 62.9M | 49.1M | 29.4M | ||
| Preferred Stock Shares Authorized | 5.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.10 | -$0.87 | -$0.63 | -$0.56 | -$0.39 | -$0.22 | -$0.18 | -$0.23 | -$0.23 | -$0.27 | -$0.34 | -$3.17 | -$2.63 | -$2.90 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 63.4M | 63.3M | 63.2M | 62.9M | 62.9M | 62.6M | 53.5M | 43.7M | 39.1M | 36.9M | 35.2M | 5.0M | 2.4M | 11.3M | |||
| Earnings Per Share Basic | $-1.10 | $-0.87 | $-0.63 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | $-2.63 | $-2.90 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 63.4M | 63.3M | 63.2M | 62.9M | 62.9M | 62.6M | 53.5M | 43.7M | 39.1M | 36.9M | 35.2M | 5.0M | 2.4M | 11.3M | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Granted During Period Value Sharebased Compensation | $12.9M | $7.3M | $7.1M | $9.7M | ||
| Prepaid Expense Current | $22.9M | $23.4M | $2.1M | $4.2M | $1.4M | $283.1K |
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$229.7M | -$121.0M | -$44.0M | -$64.5M | ||
| Additional Paid In Capital | $766.8M | $677.4M | $610.0M | $129.2M | $42.1M | |
| Stock Issued During Period Value Conversion Of Convertible Securities | $0.00 | $0.00 | ||||
| Pension Expense Reversal Of Expense Noncash | -$58.0K | $1.0K | -$85.0K | $304.0K | ||
| Other Noncash Income Expense | $1.0M | $227.0K | -$128.0K | -$68.5K | ||
| Stock Issued During Period Value New Issues | $72.4M | $52.5M | $482.5M | |||
| Depreciation | $13.2K | $12.4K | ||||
| Investment Income Interest | $27.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Granted During Period Value Sharebased Compensation | $3.7M | $3.3M | $2.3M | $1.8M | $1.8M | $1.7M | $1.4M | $1.5M | $2.6M | $2.6M | $2.5M | $2.0M | $1.9M | $1.3M | |||
| Prepaid Expense Current | $26.7M | $27.0M | $23.1M | $16.0M | $15.4M | $5.0M | $3.3M | $4.0M | $3.1M | $4.5M | $5.1M | $135.9K | $178.0K | $233.5K | $289.6K | ||
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$70.6M | -$56.0M | -$40.4M | -$36.0M | -$24.7M | -$13.9M | -$11.6M | -$12.3M | -$12.2M | -$14.7M | -$17.4M | -$15.9M | -$6.3M | -$32.7M | |||
| Additional Paid In Capital | $689.1M | $684.0M | $680.7M | $675.3M | $672.0M | $670.2M | $531.3M | $589.5M | $131.3M | $123.8M | $122.1M | $34.2M | $5.3M | $5.2M | $5.1M | $24.7K | |
| Stock Issued During Period Value Conversion Of Convertible Securities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.6K | $27.7M | ||||||||
| Pension Expense Reversal Of Expense Noncash | -$4.0K | $0.00 | -$13.3K | $77.1K | |||||||||||||
| Other Noncash Income Expense | -$124.0K | $133.0K | -$97.6K | -$4.9K | |||||||||||||
| Stock Issued During Period Value New Issues | $52.5M | $451.3M | $34.2M | $495.1K | $25.0K | ||||||||||||
| Depreciation | $22.8K | $3.3K | $2.5K | ||||||||||||||
| Investment Income Interest | $8.4K | $1.5K | $6.1K | $17.8K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.